Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
17
Number of overlapping holdings
20.2%
% of WDNA's 90 holdings also in IDNA
37.0%
% of IDNA's 51 holdings also in WDNA
Overlap by Weight
Sector Drift (WDNA minus IDNA)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in WDNA |
Weight in IDNA |
Overlap | |
|---|---|---|---|---|
 |
TWIST BIOSCIENCE CORP. | 3.3% | 3.6% | 3.3% |
 |
BIONTECH SE SPONSORED ADR | 1.3% | 4.2% | 1.3% |
|
REGENERON PHARMACEUTICALS | 1.2% | 3.7% | 1.2% |
 |
TAKEDA PHARMACEUTICAL CO LTD | 1.2% | 5.2% | 1.2% |
|
MERCK & CO. INC. | 1.1% | 3.9% | 1.1% |
Position Highlights (Non-Overlapping Exposures)
WDNA Overweight Relative to IDNA
|
NATERA INC | 3.7% |
 |
NOVOZYMES A/S-B SHARES | 2.9% |
|
ELI LILLY & CO | 2.7% |
|
BLUEPRINT MEDICINES CORP. | 2.6% |
|
VERICEL CORPORATION | 2.6% |
|
BRIDGEBIO PHARMA, INC. | 2.4% |
|
VERACYTE INC | 2.1% |
|
AGIOS PHARMACEUTICALS INC | 1.9% |
|
GILEAD SCIENCES INC | 1.9% |
|
VERTEX PHARMACEUTICALS INC | 1.8% |
WDNA Underweight Relative to IDNA
 |
BEIGENE, LTD. | -5.8% |
 |
ROCHE HOLDING LTD | -5.5% |
 |
SANOFI-AVENTIS | -5.5% |
 |
GSK PLC | -5.3% |
|
EXELIXIS INC | -5.2% |
|
ASTRAZENECA PLC | -5.1% |
|
GENMAB A/S | -4.6% |
|
SPRINGWORKS THERAPEUTICS, INC. | -4.3% |
|
TAKEDA PHARMACEUTICAL CO LTD | -4.0% |
|
INCYTE CORP | -4.0% |